Press release

Neola Medical Live at Stora Aktiedagarna in Stockholm: Showcases Strategic Advancements for Market Launch in the U.S.

Neola Medical AB will deliver a live, on-site presentation at Stora Aktiedagarna in Stockholm on November 26, 2024 at 11:20 CET (11.20). CEO Hanna Sjöström will present the company’s latest advancements, highlight the potential of Neola®, the company’s advanced medical technology device for continuous lung monitoring, and outline the strategic plans for achieving FDA approval and preparing for market launch in the U.S. Join the event live in Stockholm to watch the presentation and have the opportunity to pose questions to CEO Hanna Sjöström during the Q&A session immediately following, by registering for in-person attendance at the link here: https://invitepeople.com/events/ade744dfee

"I am excited to engage with investors and attendees in Stockholm, where I will discuss Neola Medical’s significant business advancements and outline our strategic plans toward launching in the U.S. market. We have made pivotal progress toward our FDA application, including the initiation of the essential clinical validation phase, as we prepare for our first pivotal study on preterm born infants in the U.S.”, says CEO Hanna Sjöström.

If unable to attend in Stockholm, the presentation will be streamed online at the following link: https://invitepeople.com/public/events/ade744dfee/pages/ad355f8861

The presentation will also be accessible for viewing afterward on our company website at www.neolamedical.com

About Stora Aktiedagarna
Stora Aktiedagarna in Stockholm is a three-day, action-packed event featuring around 60 company presentations from both large and small businesses. The purpose of Stora Aktiedagarna is to provide investors with objective information about the companies participating in the event. Objective information includes insights delivered directly from company leadership during their presentations, as well as questions posed by moderators to these companies. The goal is to offer the best possible information for making well-informed investment decisions. Additionally, the event aims to inspire active participation in investments and to deepen knowledge of the stock market and equity investing.

About Neola Medical
Neola Medical AB (publ) develops revolutionizing medical technology device for non-invasive continuous lung monitoring and real-time alerts of life-threatening lung complications of preterm born infants. Immediate detection of complications provides the possibility of early treatment, improved health care and healthier lives for preterm born infants. The patented cutting-edge technology is developed at Lund University in Sweden and based on a spectroscopic method that measures lung volume changes and oxygen gas concentration. Neola Medical is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to global health care. The company was founded in 2016 and is listed on NASDAQ First North Growth Market (ticker: NEOLA). Read more at www.neolamedical.com. The company’s Certified Adviser is FNCA Sweden AB.